SeraCare Life Sciences, Inc.:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SeraCare Life Sciences, Inc. - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7089
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products include next-gen sequencing and digital PCR tools, controls and reference materials, validation and lot qualification materials; plasma and serum diluents/derivatives; cell culture reagents; antibodies and conjugates; and immunoassay reagents and kits. SeraCare’s major customers include IVD manufacturers; government and regulatory agencies; and pharmaceutical and biotechnology companies; veterinary companies; and academic and government research organizations. It has facilities in Milford, Massachusetts and Gaithersburg, Maryland. The company distributes its products through a network of distributors in several countries the world over. SeraCare is headquartered in Milford, Massachusetts, the US.

SeraCare Life Sciences, Inc. – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SeraCare Life Sciences, Inc., Medical Equipment Deals By Type, 2012 to YTD 2018 6
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SeraCare Life Sciences, Inc., Medical Equipment, Deal Details 10
Private Equity 10
SeraCare Receives Shareholders Approval For Its Acquisition By Linden Capital For US$82 Million 10
Partnerships 12
SeraCare Life Sciences Enters into Agreement with ArcherDx 12
SeraCare Life Sciences Enters into R&D Agreement with National Institute of Standards and Technology 13
SeraCare Life Sciences Forms Partnership with Toma Biosciences 14
Swift Biosciences Partners with SeraCare Life Sciences 15
SeraCare Life Sciences Enters into Co-Marketing Agreement with ViveBio 16
SeraCare Life Sciences Enters into R&D Agreement with National Cancer Institute 17
Acquisition 18
SeraCare Life Sciences Acquires Kirkegaard & Perry Labs 18
SeraCare Life Sciences, Inc. – Key Competitors 19
SeraCare Life Sciences, Inc. – Key Employees 20
SeraCare Life Sciences, Inc. – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Corporate Communications 22
Jan 08, 2018: SeraCare Life Sciences Announces Joe Bernardo as New Company Chairman 22
Product News 23
Apr 16, 2018: SeraCare Announces Expansion of Industry’s Most Complete and Patient-Like ctDNA Reference Materials 23
Aug 01, 2017: SeraCare Announces the Launch of a Suite of Zika Virus Reference Materials for Improved Diagnostic Testing 24
Jul 18, 2017: SeraCare Life Sciences Announces the Most Patient-Like cfDNA QC Technology 25
Mar 23, 2017: SeraCare Life Sciences announces launch of industry’s first multiplexed Inherited Cancer reference material 26
Feb 21, 2017: SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards 27
Feb 08, 2017: SeraCare Life Sciences Announces Presentation on Enabling Clinical Genomics with Highly Multiplexed Reference Materials 28
Other Significant Developments 29
Feb 13, 2018: SeraCare Announces Industry’s First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer 29
Nov 08, 2017: SeraCare Announces Industry’s First Comprehensive NGS Reference Material for Hematologic Malignancies 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
SeraCare Life Sciences, Inc., Medical Equipment, Key Facts 2
SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SeraCare Life Sciences, Inc., Medical Equipment Deals By Type, 2012 to YTD 2018 6
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SeraCare Life Sciences, Inc., Deals By Market, 2012 to YTD 2018 8
SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SeraCare Receives Shareholders Approval For Its Acquisition By Linden Capital For US$82 Million 10
SeraCare Life Sciences Enters into Agreement with ArcherDx 12
SeraCare Life Sciences Enters into R&D Agreement with National Institute of Standards and Technology 13
SeraCare Life Sciences Forms Partnership with Toma Biosciences 14
Swift Biosciences Partners with SeraCare Life Sciences 15
SeraCare Life Sciences Enters into Co-Marketing Agreement with ViveBio 16
SeraCare Life Sciences Enters into R&D Agreement with National Cancer Institute 17
SeraCare Life Sciences Acquires Kirkegaard & Perry Labs 18
SeraCare Life Sciences, Inc., Key Competitors 19
SeraCare Life Sciences, Inc., Key Employees 20
SeraCare Life Sciences, Inc., Other Locations 21
SeraCare Life Sciences, Inc., Subsidiaries 21

List of Figures
SeraCare Life Sciences, Inc., Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SeraCare Life Sciences, Inc., Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SeraCare Life Sciences, Inc., Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SeraCare Life Sciences, Inc.:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Protagen AG-医療機器分野:企業M&A・提携分析
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • Laboratorios Farmaceuticos Rovi SA (ROVI):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products …
  • 4imprint Group plc (FOUR):企業の財務・戦略的SWOT分析
    4imprint Group plc (FOUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ELMOS Semiconductor AG (ELG):企業の財務・戦略的SWOT分析
    ELMOS Semiconductor AG (ELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Konsortium Transnasional Berhad:企業の戦略・SWOT・財務情報
    Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • GTx Inc (GTXI):製薬・医療:M&Aディール及び事業提携情報
    Summary GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical condition …
  • CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報
    Summary CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, …
  • Sensus BV:企業の戦略・SWOT・財務情報
    Sensus BV - Strategy, SWOT and Corporate Finance Report Summary Sensus BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Malee Group Public Company Limited:企業の戦略・SWOT・財務情報
    Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Malee Group Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Hang Lung Properties Limited:企業の戦略・SWOT・財務情報
    Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report Summary Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Newron Pharmaceuticals SpA (NWRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Newron Pharmaceuticals SpA (Newron) is a research-based biopharmaceutical company which focuses on the discovery, development and commercialization of novel therapeutic drugs for the treatment of central nervous system disorders and pain. The company’s marketed product, Xadago (safinamide), …
  • National Power Corp:企業の戦略的SWOT分析
    National Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Alcoa Corp:企業の戦略・SWOT・財務情報
    Alcoa Corp - Strategy, SWOT and Corporate Finance Report Summary Alcoa Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Pacific & Orient Berhad:企業の戦略・SWOT・財務分析
    Pacific & Orient Berhad - Strategy, SWOT and Corporate Finance Report Summary Pacific & Orient Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Wartsila Corp (WRT1V):電力:M&Aディール及び事業提携情報
    Summary Wartsila Corp (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vessels and …
  • Trubnaya Metallurgicheskaya Kompaniya:企業の戦略・SWOT・財務情報
    Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report Summary Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Medigen Vaccine Biologics Corp (6547):製薬・医療:M&Aディール及び事業提携情報
    Summary Medigen Vaccine Biologics Corp (MVC) a subsidiary of Medigen Biotechnology Corp is a biopharmaceutical company with focus on the development and production of vaccines and biologics. Its research and development pipeline includes EV71 vaccine to prevent enterovirus infection; H5N1 and H7N9 m …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Emerald Health Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Sciences Inc (EHS) focuses to advance the development of cannabis in pharmaceutical, botanical and bioceutical applications. The company is developing EHP-101 based on cannabidiol for the treatment of multiple sclerosis (MS) and scleroderma; and EHP-102, derived from cannabige …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆